Drugs / AZD8108
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02248818 | Nov 2014 → Sep 2015 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD8108 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02248818 ↗ |
| Route | Oral | “administered orally as a solution.” NCT02248818 ↗ |